Biophore
Hyderabad, India· Est.
Biophore is a CDMO delivering fast, regulated API and specialty drug manufacturing for global pharma partners.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Biophore is a CDMO delivering fast, regulated API and specialty drug manufacturing for global pharma partners.
OncologyContrast AgentsPeptidesInjectable APIsOrphan Drugs
Technology Platform
A robust small‑molecule synthesis platform combining high‑potency API manufacturing, complex intermediates, and GMP‑compliant facilities with extensive DMF and CEP coverage.
Opportunities
Expanding demand for outsourced API manufacturing and specialty drug production, especially in oncology and orphan indications, offers significant growth potential.
Risk Factors
Regulatory compliance across multiple jurisdictions and competition from larger CDMOs could constrain margins and market share.
Competitive Landscape
Competes with global CDMOs such as Lonza, WuXi, and Catalent; differentiation lies in niche small‑molecule expertise and rapid DMF generation.